gms | German Medical Science

27th German Cancer Congress Berlin 2006

German Cancer Society (Frankfurt/M.)

22. - 26.03.2006, Berlin

Basic documentation in psycho-oncology. Development and psychometric validation of two specific tools: a) PO-Bado-Mamma - a breast cancer specific version and b) PO-Bado-KF - a short form

Meeting Abstract

  • corresponding author presenting/speaker Birgitt Marten-Mittag - Institut und Poliklinik für Psychosomatische Medizin, Psychotherapie und Med. Psychologie, Klin. r. d. Isar, TU München, Deutschland
  • Birgit Huber - Institut und Poliklinik für Psychosomatische Medizin, Psychotherapie und Med. Psychologie, Klin. r. d. Isar, TU München
  • Celia Pirker - Institut und Poliklinik für Psychosomatische Medizin, Psychotherapie und Med. Psychologie, Klin. r. d. Isar, TU München
  • Monika Mussel - Sektion Psychoonkologie, Abt. f. Psychosomatik u. allg. klin. Medizin, Universität Heidelberg
  • Monika Keller - Sektion Psychoonkologie, Abt. f. Psychosomatik u. allg. klin. Medizin, Universität Heidelberg
  • Peter Herschbach - Institut und Poliklinik für Psychosomatische Medizin, Psychotherapie und Med. Psychologie, Klin. r. d. Isar, TU München

27. Deutscher Krebskongress. Berlin, 22.-26.03.2006. Düsseldorf, Köln: German Medical Science; 2006. DocPO572

The electronic version of this article is the complete one and can be found online at: http://www.egms.de/en/meetings/dkk2006/06dkk682.shtml

Published: March 20, 2006

© 2006 Marten-Mittag et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Background: Clinical experience in psychooncological screening by means of the PO-Bado shows both high acceptance and substantial demand for specific tools for special settings. The development of two specific versions will be described: a) a disease specific version for breast cancer patients and b) a shortform of PO-Bado which can be easily integrated into the medical history interview.

Methods: a) The preliminary version of the breast cancer specific tool consists of all items of the standard PO-Bado and 7 breast cancer related items selected from the most frequent stress statements in semi-structured interviews with breast cancer patients. 80 breast cancer patients were assessed with the preliminary version. Additionally they filled in 3 psychometric evaluated questionnaires (HADS, QSC-R23 and EORTC-QLQ-C30).

b) The most important items from PO-Bado (criterion: mean score; data: primary validation sample n = 700) were selected for the preliminary short form. This 9-item –scale was applied to 150 patients of different treatment settings. For validation two psychometrically evaluated questionnaires were administered concurrently (HADS-D Hospital Anxiety and Depression Scale; QSC-R23 Questionnaire on Stress in Cancer Patients). To test interrater reliability 20 audio-taped interviews were rated by 3 independent raters.

Results: Results concerning construct validity, interrater reliability and sensitivity to change of the two new PO-Bado-instruments will be presented.

The project is supported by Deutsche Arbeitsgemeinschaft für Psychosoziale Onkologie e.V. (dapo), Arbeitsgemeinschaft für Psychoonkologe (PSO) and Deutsche Krebshilfe e.V.